These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33207783)

  • 1. Reconsidering Aromatase for Breast Cancer Treatment: New Roles for an Old Target.
    Caciolla J; Bisi A; Belluti F; Rampa A; Gobbi S
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33207783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death.
    Cepa M; Correia-da-Silva G; da Silva EJ; Roleira FM; Borges M; Teixeira NA
    BMC Cell Biol; 2008 Jul; 9():41. PubMed ID: 18652661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase, aromatase inhibitors, and breast cancer.
    Chumsri S; Howes T; Bao T; Sabnis G; Brodie A
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):13-22. PubMed ID: 21335088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
    Ahmad I; Shagufta
    Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal aromatase inhibitors for the treatment of breast cancer: an update.
    Gobbi S; Rampa A; Belluti F; Bisi A
    Anticancer Agents Med Chem; 2014 Jan; 14(1):54-65. PubMed ID: 23869785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.
    Jordan VC; Brodie AM
    Steroids; 2007 Jan; 72(1):7-25. PubMed ID: 17169390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen signaling: An emanating therapeutic target for breast cancer treatment.
    Saha T; Makar S; Swetha R; Gutti G; Singh SK
    Eur J Med Chem; 2019 Sep; 177():116-143. PubMed ID: 31129450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatase Inhibitors for the Treatment of Breast Cancer: A Journey from the Scratch.
    Ratre P; Mishra K; Dubey A; Vyas A; Jain A; Thareja S
    Anticancer Agents Med Chem; 2020; 20(17):1994-2004. PubMed ID: 32593281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advancement in nonsteroidal aromatase inhibitors for treatment of estrogen-dependent breast cancer.
    Jiao J; Xiang H; Liao Q
    Curr Med Chem; 2010; 17(30):3476-87. PubMed ID: 20738251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase inhibitors in breast cancer.
    Hiscox S; Davies EL; Barrett-Lee P
    Maturitas; 2009 Aug; 63(4):275-9. PubMed ID: 19577386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Aromatase-Sulphatase Inhibitors (DASIs) for the Treatment of Hormone Dependent Breast Cancer.
    Banjare L; Jain AK; Thareja S
    Mini Rev Med Chem; 2021; 21(20):3144-3165. PubMed ID: 33463462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase inhibitors in the treatment of breast cancer.
    Brueggemeier RW; Hackett JC; Diaz-Cruz ES
    Endocr Rev; 2005 May; 26(3):331-45. PubMed ID: 15814851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the mechanisms of aromatase inhibitor resistance.
    Miller WR; Larionov AA
    Breast Cancer Res; 2012 Jan; 14(1):201. PubMed ID: 22277572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal aromatase inhibitors.
    Adhikari N; Baidya SK; Jha T
    Eur J Med Chem; 2020 Dec; 208():112845. PubMed ID: 33017749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase: the enzyme and its inhibition.
    Banting L; Ahmed S
    Anticancer Agents Med Chem; 2009 Jul; 9(6):627-41. PubMed ID: 19601746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities.
    Lv W; Liu J; Skaar TC; Flockhart DA; Cushman M
    J Med Chem; 2015 Mar; 58(6):2623-48. PubMed ID: 25751283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of aromatase expression: Potential therapeutic insight into breast cancer treatment.
    Molehin D; Filleur S; Pruitt K
    Mol Cell Endocrinol; 2021 Jul; 531():111321. PubMed ID: 33992735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors.
    Augusto TV; Amaral C; Varela CL; Bernardo F; da Silva ET; Roleira FFM; Costa S; Teixeira N; Correia-da-Silva G
    J Steroid Biochem Mol Biol; 2019 Dec; 195():105486. PubMed ID: 31557516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase Inhibitors Evolution as Potential Class of Drugs in the Treatment of Postmenopausal Breast Cancer Women.
    Avvaru SP; Noolvi MN; Aminbhavi TM; Chkraborty S; Dash A; Shukla SS
    Mini Rev Med Chem; 2018; 18(7):609-621. PubMed ID: 29090666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of aromatase and its inhibitors in dealing with different oncological pathologies other than breast cancer].
    Bershteĭn LM; Barchuk AS; Gershfel'd ED; Kovalevskiĭ AIu; Maksimov SIa; Danilova MA; Barash IuA; Meshkova IE; Moiseenko VM; Novik AV; Pozharisskiĭ KM; Semiglazov VF; Tsyrlina EV; Chernobrovkina AE
    Vopr Onkol; 2007; 53(1):7-13. PubMed ID: 17649727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.